Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calix Limited is an Australian environmental technology company that leverages its patented Calix Flash Calcination (CFC) platform to develop "nano-active" materials for diverse global challenges. The company's Biotech division focuses on producing high-surface-area magnesium oxide materials with enhanced bioactivity for applications in agriculture, aquaculture, and human health. Key products include BOOSTER-Mag for sustainable crop protection and AQUA-Cal+ for water treatment in aquaculture. Calix is also actively researching the use of its bioactive materials to combat antimicrobial resistance (AMR) and develop antimicrobial coatings for medical and industrial use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calix.